Care plan to help reduce death risk in advanced HIV
Part of Infections clinical trials.
This Phase 3 study tests an enhanced clinic care package for adults with advanced HIV to lower the risk of death. It may help by improving follow-up and treatment support for people who need closer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your most recent CD4 count is below 200 (a blood test that shows advanced immune weakness).
- You can understand the study and sign consent to join the enhanced care group.
- Your HIV viral load was not already well controlled: in the last 3 months it was not below 1,000 copies/mL.
- You are able and likely to attend regular clinic visits (and not plan to miss them).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This trial tests a program to help people with advanced HIV stay in care after being hospitalized. If you have a very low CD4 count or a serious HIV-related illness, this study may offer extra support to keep you healthy.
This trial looks at whether staying in contact with patients after they leave the hospital helps them get better follow-up care. If you have advanced HIV and are in the hospital for a related illness, you may be able to join.
This trial offers a new way to manage HIV care for people who also have heart or metabolic problems like high blood pressure, diabetes, or high cholesterol. It aims to see if combining specialist care with HIV care can improve health outcomes.
This Phase 3 study tests whether adding azithromycin helps people with advanced HIV disease live longer. You would start (or restart or adjust) HIV treatment within 4 weeks and may also receive azithromycin or a comparison approach to see if outcomes improve.
This trial looks at how care is being provided to adults with HIV who may be on treatment or not, and regardless of immune strength. It may help improve future care plans by identifying what works best in real-world settings.
Hear when a new The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.